

The development of sophisticated three-dimensional (3-D) cell culture microenvironments that recreate some of the complexity of the natural extracellular matrix (ECM) remains a challenging task. Here, the modification of alginate through partial crosslinking with a matrix metalloproteinase (MMP) cleavable peptide (proline-valine-glycine-leucine-isoleucine-glycine, PVGLIG) is described, and its use in the preparation of injectable, in situ crosslinkable hydrogel-like matrices is proposed. PVGLIG-grafted alginates were synthesized by carbodiimide chemistry and characterized. Their biological performance was evaluated by comparing the response of 3-D cultured mesenchymal stem cells (MSCs) to alginate hydrogels containing only cell-adhesion peptides (RGD-alginate) or both peptides (PVGLIG/RGD-alginate). After 1 week, cells remained essentially round within RGD-alginate, while they exhibited an elongated morphology within PVGLIG/RGD-alginate hydrogels, forming cellular networks. This suggests that cells were able to structurally reorganize the matrix, through enzymatic hydrolysis of PVGLIG residues, overcoming biophysical hydrogel resistance. As shown by gelatine-zymography, MSC presented higher activity of MMP-2 when cultured within alginate functionalized with MMP-sensitive peptide, suggesting that the cell's proteolytic phenotype was modulated by the matrix composition. Additionally, PVGLIG/RGD-alginate hydrogels were clearly degraded in cell culture. Taken together, the results demonstrate that the co-incorporation of MMP-labile peptides in cell-adhesive RGD-alginate hydrogels improved their performance as ECM analogues, providing a more dynamic and physiological 3-D cellular microenvironment. © 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
| EMTREE drug terms: | alginic acidgelatingelatinase Amatrix metalloproteinasepeptide derivativeprolylvalylglycylleucylisoleucylglycineunclassified drug |
|---|---|
| EMTREE medical terms: | articlecell adhesioncell compositioncell culturecell structurecell viabilitycontrolled studyenzyme activityextracellular matrixhumanhuman cellhydrogelhydrolysismesenchymal stem cellmorphologyphenotypepriority journalprotein cleavageprotein degradationtumor microenvironmentzymography |
| MeSH: | AlginatesAmino Acid SequenceCell CountCell Culture TechniquesCell ShapeCell SurvivalCells, CulturedEnzyme ActivationGlucuronic AcidHexuronic AcidsHumansHydrogelsMatrix MetalloproteinasesMesenchymal Stem CellsMolecular Sequence DataPeptidesProtein Processing, Post-TranslationalSubcellular Fractions |
alginic acid, 28961-37-7, 29894-36-8, 9005-32-7, 9005-38-3; gelatin, 9000-70-8; gelatinase A, 146480-35-5;
Alginates; Glucuronic Acid, 576-37-4; Hexuronic Acids; Hydrogels; Matrix Metalloproteinases, 3.4.24.-; Peptides; alginic acid, 9005-32-7
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Fuel Cell Technologies Program | SFRH/BD/30057/2006,COMPETE FCOMP-01-0124-FEDER-010915,PTDC/SAU-BEB/101235/2008 |
The authors would like to thank to Catarina Almeida (CLSM), Filipe Cruz (technical support) and Anabela Nunes (image design). K.F. is grateful to the Portuguese Foundation for Science and Technology (FCT) for PhD grant SFRH/BD/30057/2006 . C.B. also acknowledges the Ciência 2008 program. This work was carried out under the contract PTDC/SAU-BEB/101235/2008 and COMPETE FCOMP-01-0124-FEDER-010915. Appendix A
Barrias, C. C.; INEB, Instituto de Engenharia Biomédica, Divisão de Biomateriais, Universidade Do Porto, Rua do Campo Alegre 823, Portugal;
© Copyright 2011 Elsevier B.V., All rights reserved.
© MEDLINE® is the source for the MeSH terms of this document.